Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 48

Sponsor: University Hospital, Bordeaux

Location: CHU de Bordeaux - Service d'Immunologie et Immunogénétique Bordeaux

Summary

The study aims at defining the role of soluble CD95 Ligand in the physiopathology of a rare group of inflammatory diseases: ANCA associated vasculitis. Soluble CD95 Ligand might have a prognostic and diagnostic interest as well as potential for the discovery of new therapeutic strategies.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of ANCA associated vasculitis according to the Chapel-Hill Consensus Conference - 2012 modified version * Age ≥ 18 years * being affiliated to health insurance * willing to participate and to sign informed consent. Exclusion Criteria: * Pregnant or breastfeeding women, * patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03698071). StuddyBuddy aggregates publicly available trial information.